1,766
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

White-coat hypertension detected during opportunistic blood pressure screening in a dental healthcare setting

, &
Pages 348-354 | Received 08 Apr 2020, Accepted 26 Apr 2021, Published online: 04 Aug 2021

References

  • Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–2260.
  • Lindholm LH, Carlberg B. Moderately elevated blood pressure. A systematic literature review. Volumes1 & 2. Stockholm: the Swedish Council on Technology Assessment in Health Care 2004. SBU-rapport. 2004;170 = 1:1–514. and 170 = 2:1–248.
  • Lindholt JS, Sogaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet. 2017;390(10109):2256–2265.
  • Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953–2041.
  • Swedish Social Insurance Agency, Social insurance report [Internet]. [p. 74]. 2012. www.socialstyrelsen.se/publikationer2012/2012-2-2/Documents/Tandvardoch-tandhalsa.pdf.
  • Engstrom S, Berne C, Gahnberg L, et al. Efficacy of screening for high blood pressure in dental health care. BMC PublicHealth. 2011;11:194.
  • Greenberg BL, Glick M. Assessing systemic disease risk in a dental setting: a public health perspective. Dent Clin North Am. 2012;56(4):863–874.
  • Andersson H, Hedström L, Bergman S, et al. The outcome of two-step blood pressure screening in dental healthcare. Scand J Public Health. 2018;46(6):623–629.
  • Mancia G, Bombelli M, Seravalle G, et al. Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol. 2011;8(12):686–693.
  • Kario K, Thijs L, Staessen JA. Blood pressure measurement and treatment decisions: masked and white coat hypertension. Circ Res. 2019;124(7):990–1008.
  • Huang Y, Huang W, Mai W, et al. White-coat hypertension is a risk factor for cardiovascular diseases and total mortality. J Hypertens. 2017;35(4):677–688.
  • Mancia G, Bombelli M, Cuspidi C, et al. Cardiovascular risk associated with white-coat hypertension: pro side of the argument. Hypertension. 2017;70(4):668–675.
  • Celis H, Fagard RH. White-coat hypertension: a clinical review. Eur J Intern Med. 2004;15(6):348–357.
  • Noubiap JJ, Nansseu JR, Nkeck JR, et al. Prevalence of white coat and masked hypertension in Africa: a systematic review and meta-analysis. J Clin Hypertens. 2018;20(8):1165–1172.
  • Gerin W, Marion RM, Friedman R, et al. How should we measure blood pressure in the doctor’s office? Blood Press Monit. 2001;6(5):257–262.
  • Elfström ML, Lundgren J, Berggren U. Methodological assessment of behavioural problem dimensions in adult with dental fear. Commun Dent Oral Epidemiol. 2007;35(3):186–194.
  • Belghazi J, El Feghali RN, Moussalem T, et al. Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension. Vasc Health Risk Manag. 2007;3:389–400.
  • Sheppard JP, Fletcher B, Gill P, et al. Predictors of the home-clinic blood pressure difference: a systematic review and meta-analysis. Am J Hypertens. 2016;29(5):614–625.
  • Sprafka JM, Strickland D, Gómez-Marin O, et al. The effect of cuff size on blood pressure measurement in adults. Epidemiology. 1991;2(3):214–217.
  • Hänninen MR, Niiranen TJ, Puukka PJ, et al. Target organ damage and masked hypertension in the general population: the Finn-Home study. J Hypertens. 2013;31(6):1136–1143.
  • Public health agency of Sweden. Livsvillkor & levnadsvanor [Internet]. Stockholm: Public health agency of Sweden; 2020. [updated 2020 May 22; cited 2020 Dec 07]. Available from: https://www.folkhalsomyndigheten.se/livsvillkor-levnadsvanor/andts/utveckling-inom-andts-anvandning-och-ohalsa/bruk/tobak-och-liknande-produkter/vuxnas-bruk-av-cigaretter-snus-och-e-cigaretter/.
  • Prasad GL, Jones BA, Chen P, et al. A cross-sectional study of biomarkers of exposure and effect in smokers and moist snuff consumers. Clin Chem Lab Med. 2016;54(4):633–642.
  • U.S. Department of Health and Human Services CfDCaP, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and, Health. How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General; 2010.